TMPRSS4 and cancer: Recently, 2-hydroxydiarylamide derivatives, IMD-0354 and KRT1853, were developed as TMPRSS4 serine protease inhibitors.32 These new compounds have been shown to inhibit cancer cell invasion, migration, and proliferation; however, the sensitivity to chemotherapy was not determined.